Sun Pharmaceutical to Commence COVID-19 Clinical Trials Targeting Generic Nafamostat Mesylate TrialSite News, 31 May 2020 The Sun Pharmaceutical Industries Ltd announced approval from Indian drug authority known as the Drugs Controller General of…